Buy-Side Advisory · UK & US
Buy a pharmacy business.
Curated, pre-qualified community, online and specialist pharmacy opportunities across the UK and US, suited to operators, groups and platforms.
£500K–£50M
Enterprise Value
UK & US
Coverage
Free
For Acquirers
Share Your Acquisition Criteria
Get matched with curated, pre-qualified businesses in your target sectors. Takes 2 minutes.
Free. Confidential. No spam.
Why buyers are acquiring pharmacy businesses
Defensive prescription revenue
Dispensing income is anchored to ageing demographics and chronic-disease prescribing — defensive through the cycle.
Service revenue expansion
NHS-funded services in the UK (Pharmacy First, vaccinations) and clinical services in the US are widening the revenue mix beyond pure dispensing.
Online and DTC growth
Online pharmacy and DTC clinical brands are growing fast and represent a separate, distinct buyer pool to bricks-and-mortar acquirers.
Pharmacie sub-niches we cover
Community Pharmacy (Single Site)
Standalone bricks-and-mortar pharmacies in residential and high-street locations.
Pharmacy Groups
Multi-site community groups suited to consolidator bolt-on.
Online / Distance-Selling
Online pharmacies, often combined with a DTC clinical brand.
Specialist / Compounding
Specialist compounding and clinical pharmacies serving niche patient cohorts.
Care-Home Dispensing
B2B dispensing to care-home estates, contract-led.
What pharmacy businesses actually trade for
Pharmacy valuations are driven by prescription volume, service mix, location quality and pharmacist retention. Online pharmacy and clinical-services-led businesses can attract very different multiples to traditional bricks-and-mortar dispensaries.
Mandates we surface generally sit between £500K and £50M in enterprise value, with most opportunities concentrated in the £1M–£20M range.
Due diligence focus areas for pharmacy acquisitions
The diligence themes most likely to move price, deal structure or completion certainty.
Prescription volume and item growth
Audit dispensing volume, item-mix and recent like-for-like growth — the foundation of pharmacy valuation.
Service revenue mix and contract status
Review service revenue (Pharmacy First, vaccinations, clinical services) and any contract dependencies.
Pharmacist retention and locum reliance
Responsible pharmacist availability is a real operational risk — review contracts, attrition and locum spend.
Stock and controlled drug audit
Stock valuation, expiry exposure and controlled drug records require careful diligence.
GPhC / state board standing
Review last inspection, any conditions or open enforcement matters.
Backed by investors behind Uber, SpaceX, Canva, Notion and others, to modernise M&A advisory for business owners and buyers like you.
We have raised investment from the same backers behind companies that transformed entire industries.
Capital is being deployed to keep delivering successful exits — sharper buyer mapping, a stronger advisory bench, and a faster process for owners.
Other buyside opportunities
Owner of a pharmacy business?
Considering a sale of your pharmacy business?
DealFlowAgent runs the deal flow engine that connects pharmacy owners with credible acquirers across the UK and US.
See our sell-side service